Bioline Rx reported $7.94M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Bio Path USD 261K 261K Mar/2025
Bioline Rx USD 7.94M 1.13M Jun/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025